Patent Foramen Ovale (PFO) and Risk of Perioperative Stroke
NCT ID: NCT05592301
Last Updated: 2023-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
408 participants
OBSERVATIONAL
2023-07-07
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patent Foramen Ovale Closure in Older Patients
NCT04780022
Angiography-derived FFR GPS in Predicting Post-PCI Physiological and Clinical Outcomes
NCT05496023
PrOgnostic Implications of PRe-stent Pullback Pressure GradIent and Post-stent Quantitative Flow Ratio in Patients UnderGoing Percutaneous Coronary INtervention
NCT05104580
A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Coherence Tomography Guided PCI in STEMI Patients Without Undergoing Primary PCI
NCT04996277
Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery
NCT01288105
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients referred for general, orthopedic, urological, gynecologic, spinal, or thoracic surgery will be screened and consented during the surgery pre-admission clinic visit, and then undergo PFO screening using transcranial Doppler (TCD) and transthoracic echocardiography (TTE). Patients screened PFO+ (n=102) and matched PFO- controls (n=102) will have DW-MRI between postoperative days 2 and 7. Study personnel will conduct phone surveys at 30-day and 1-year post-surgery to collect data on other clinical outcomes. Patients will also be administered cognitive and patient-reported outcome measures assessments before enrollment, and 30-day and 1-year follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical patients
Patients undergoing major non-cardiac, non-vascular, and non-brain surgery who will be examined for a presence of PFO
Diffusion-weighted Magnetic Resonance Imaging (DW-MRI)
The Diffusion-weighted Magnetic Resonance Imaging (DW-MRI) is used to diagnose perioperative stroke.
Transcranial Doppler (TCD)
Used to diagnose PFO
Transthoracic Echocardiogram (TTE)
Used to diagnose PFO.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diffusion-weighted Magnetic Resonance Imaging (DW-MRI)
The Diffusion-weighted Magnetic Resonance Imaging (DW-MRI) is used to diagnose perioperative stroke.
Transcranial Doppler (TCD)
Used to diagnose PFO
Transthoracic Echocardiogram (TTE)
Used to diagnose PFO.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. referred for an elective, non-cardiac, non-vascular and non-brain surgery;
3. with an estimated hospital length of stay ≥2 days. We will include patients referred for general, orthopedic, urological, gynecologic, spinal or thoracic surgery.
Exclusion Criteria
2. those with comorbidities that potentially increase the risk of perioperative stroke;
3. contraindications to MRI;
4. unable to complete or adhere to the study.
18 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peter Munk Cardiac Centre
UNKNOWN
University Health Network, Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric Horlick
Director, Structural Heart Disease
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Horlick, MD
Role: PRINCIPAL_INVESTIGATOR
University Health Network, Peter Munk Cardiac Centre
Lusine Abrahamyan, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Health Network, Theta Collaborative
Aleksandra Pikula, MD
Role: PRINCIPAL_INVESTIGATOR
University Heath Network, Division of Neurology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toronto General Hospital, UHN
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Hobbes B, Akseer S, Pikula A, Huszti E, Devereaux PJ, Horlick E, Abrahamyan L. Risk of Perioperative Stroke in Patients With Patent Foramen Ovale: A Systematic Review and Meta-analysis. Can J Cardiol. 2022 Aug;38(8):1189-1200. doi: 10.1016/j.cjca.2022.02.026. Epub 2022 Mar 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAPPRES
Identifier Type: OTHER
Identifier Source: secondary_id
21-5671
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.